Of the 34 patients enrolled in Cohort 3 of the ATALANTA-1 Phase 1/2 study, 32 received GLPG5101; 94% were infused…
June 11, 2025 17:49 ET | Source: MediPharm Labs Corp. TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp.…